Learn about cardiac glycosides, their classification, natural sources, mechanism of action, therapeutic uses, examples, adverse effects, and pharmacognostic importance.
Introduction
Cardiac glycosides are a group of naturally occurring steroidal glycosides that have a powerful effect on the heart. They are important pharmacologically because certain cardiac glycosides increase the force of cardiac contraction and have historically been used in the management of heart failure and certain supraventricular cardiac arrhythmias.
The most well-known sources of cardiac glycosides are plants belonging to the genera Digitalis, Strophanthus, and Convallaria. Among these, Digitalis purpurea (foxglove) and Digitalis lanata are particularly important medicinal plants.
Cardiac glycosides are an important topic in pharmacognosy, pharmacology, medicinal chemistry, and pharmaceutical sciences because they demonstrate the relationship between natural products and clinically important drugs.
What Are Cardiac Glycosides?
Cardiac glycosides are steroidal glycosides that exert a direct action on cardiac muscle. Chemically, they consist of two major portions:
- Aglycone (genin) – the non-sugar portion responsible for most of the pharmacological activity.
- Sugar moiety – the carbohydrate portion that influences solubility, pharmacokinetics, and interaction with the aglycone.
The aglycone contains a steroid nucleus and an unsaturated lactone ring at C-17. The nature of this lactone ring is an important basis for classifying cardiac glycosides.
Chemical Structure of Cardiac Glycosides
A typical cardiac glycoside contains:
- A steroidal nucleus
- An unsaturated lactone ring
- One or more sugar residues
The steroid portion is commonly referred to as the aglycone or genin, while the sugar component is known as the glycone.
The sugar component may include sugars such as:
- Digitoxose
- Glucose
- Rhamnose
- Cymarose
The number and type of sugar residues can differ among individual cardiac glycosides.
Classification of Cardiac Glycosides
Cardiac glycosides can be classified according to the type of lactone ring attached to the steroid nucleus.
1. Cardenolides
Cardenolides contain a five-membered unsaturated lactone ring.
They are the most important cardiac glycosides found in many medicinal plants.
Examples
- Digoxin
- Digitoxin
- Gitoxin
- Lanatoside C
- Ouabain
Important Sources
- Digitalis purpurea
- Digitalis lanata
- Strophanthus species
- Convallaria majalis
2. Bufadienolides
Bufadienolides contain a six-membered doubly unsaturated lactone ring.
They occur mainly in certain plants and animal sources and are generally less important therapeutically than the cardenolides.
Examples
- Proscillaridin
- Scillaren
Important Plant Source
- Drimia maritima (formerly Urginea maritima), commonly known as squill.
Cardenolides vs Bufadienolides
| Feature | Cardenolides | Bufadienolides |
|---|---|---|
| Lactone ring | Five-membered | Six-membered |
| Unsaturation | One double bond | Two double bonds |
| Common examples | Digoxin, digitoxin | Proscillaridin, scillaren |
| Important sources | Digitalis, Strophanthus | Squill |
| Pharmacological importance | Very high | Comparatively limited |
Major Natural Sources of Cardiac Glycosides
Several medicinal plants contain cardiac glycosides.
1. Digitalis purpurea
Common name: Purple foxglove
Digitalis purpurea is one of the classic sources of cardiac glycosides. Its leaves contain several cardenolide glycosides, including compounds related to digitoxin and gitoxin.
2. Digitalis lanata
Common name: Woolly foxglove
Digitalis lanata is particularly important as a source of digoxin and related glycosides.
Digoxin is one of the best-known cardiac glycosides used clinically.
3. Strophanthus Species
Species of Strophanthus contain cardiac glycosides such as ouabain (g-strophanthin).
Historically, preparations obtained from Strophanthus were used as cardiac medicines.
4. Convallaria majalis
Common name: Lily of the valley
Convallaria majalis contains cardiac glycosides such as convallatoxin.
The plant is pharmacologically active but potentially toxic and is not generally used as a source of self-administered cardiac treatment.
5. Drimia maritima
Common name: Squill
Squill contains bufadienolide cardiac glycosides, including compounds such as proscillaridin.
Important Cardiac Glycosides
| Cardiac Glycoside | Major Source | Type |
|---|---|---|
| Digoxin | Digitalis lanata | Cardenolide |
| Digitoxin | Digitalis purpurea | Cardenolide |
| Gitoxin | Digitalis species | Cardenolide |
| Ouabain | Strophanthus species | Cardenolide |
| Convallatoxin | Convallaria majalis | Cardenolide |
| Proscillaridin | Squill | Bufadienolide |
| Scillaren | Squill | Bufadienolide |
Mechanism of Action of Cardiac Glycosides
The primary pharmacological action of cardiac glycosides is inhibition of the Na⁺/K⁺-ATPase pump in cardiac muscle cells.
Under normal conditions, Na⁺/K⁺-ATPase transports sodium out of the cell and potassium into the cell.
Cardiac glycosides inhibit this pump, resulting in:
Na⁺/K⁺-ATPase inhibition → increased intracellular Na⁺ → reduced Na⁺/Ca²⁺ exchange → increased intracellular Ca²⁺ → increased cardiac contractility
This increase in the force of cardiac contraction is known as a positive inotropic effect.
Effects on the Heart
Cardiac glycosides can produce several important cardiovascular effects.
Positive Inotropic Effect
They increase the force of contraction of the cardiac muscle.
This can improve cardiac output in selected patients with heart failure.
Negative Chronotropic Effect
Some cardiac glycosides, particularly digoxin, decrease the heart rate.
Negative Dromotropic Effect
They slow conduction through the atrioventricular (AV) node, which can be useful in controlling ventricular response in certain supraventricular arrhythmias.
Therapeutic Uses of Cardiac Glycosides
The clinical use of cardiac glycosides has changed considerably because of their narrow therapeutic index and the availability of newer treatments.
1. Heart Failure
Digoxin may be used in selected patients with heart failure, particularly when additional symptom control is required despite guideline-directed therapy.
It can increase myocardial contractility and may improve symptoms.
2. Atrial Fibrillation
Digoxin can be used for ventricular rate control in atrial fibrillation, particularly in selected patients.
Its effectiveness and suitability depend on the patient’s clinical condition and other medications.
3. Atrial Flutter
Cardiac glycosides have historically been used to help control ventricular rate in atrial flutter.
Digoxin
Digoxin is one of the most clinically important cardiac glycosides.
It is obtained from Digitalis lanata and has a relatively long history of use in cardiovascular medicine.
Important characteristics
- Cardiac glycoside
- Cardenolide
- Derived from Digitalis lanata
- Inhibits Na⁺/K⁺-ATPase
- Produces positive inotropic effects
- Influences AV nodal conduction
- Has a narrow therapeutic index
Because the difference between therapeutic and toxic concentrations can be relatively small, digoxin therapy requires careful clinical management.
Digitoxin
Digitoxin is another important cardiac glycoside associated with Digitalis purpurea.
Compared with digoxin, digitoxin has different pharmacokinetic characteristics, including greater lipid solubility and a much longer elimination half-life.
Its clinical use has declined substantially compared with digoxin.
Pharmacognostic Importance of Cardiac Glycosides
Cardiac glycoside-containing plants are important crude drugs in pharmacognosy.
The pharmacognostic study of these drugs may include:
- Biological source
- Family
- Geographical distribution
- Macroscopic characters
- Microscopic characters
- Chemical constituents
- Identification tests
- Extraction methods
- Assay
- Therapeutic uses
- Adulterants
- Toxicity
Digitalis leaves are particularly important in pharmacognosy because they contain potent cardiac glycosides and require careful standardization.
Chemical Tests for Cardiac Glycosides
Several classical pharmacognostic tests can be used for detecting cardiac glycosides.
1. Keller–Kiliani Test
The Keller–Kiliani test is commonly used to detect cardiac glycosides containing deoxy sugars.
A positive test may produce a characteristic color reaction at the interface of the layers.
2. Legal Test
The Legal test is used for detecting cardenolides.
It involves a reaction associated with the unsaturated lactone ring and can produce a pink to red coloration under suitable conditions.
3. Baljet Test
The Baljet test is another classical test used for detecting cardenolide-type compounds.
An orange to red coloration may indicate the presence of an active lactone system.
4. Kedde Test
The Kedde test is based on the reaction of the unsaturated lactone ring with suitable reagents and can produce a violet or purple color.
These tests are primarily useful as qualitative pharmacognostic tests and are not substitutes for modern quantitative analytical methods.
Toxicity of Cardiac Glycosides
Cardiac glycosides have a narrow therapeutic index, meaning that the difference between an effective dose and a toxic dose can be relatively small.
Excessive exposure may result in:
- Nausea
- Vomiting
- Loss of appetite
- Abdominal discomfort
- Dizziness
- Confusion
- Visual disturbances
- Bradycardia
- Various cardiac arrhythmias
Severe poisoning can be life-threatening.
For this reason, cardiac glycoside-containing plants should not be used for self-treatment.
Factors Affecting Digoxin Toxicity
Several factors can increase the risk of cardiac glycoside toxicity, including:
- Renal impairment
- Electrolyte abnormalities
- Drug interactions
- Advanced age
- Excessive dosage
- Reduced clearance
- Certain cardiovascular conditions
Hypokalemia, in particular, can increase the susceptibility of the Na⁺/K⁺-ATPase to digoxin and contribute to toxicity.
Cardiac Glycosides in Pharmacognosy
Cardiac glycosides represent an important class of natural products with potent pharmacological activity.
From a pharmacognosy perspective, important topics include:
Biological Sources
Plants such as Digitalis, Strophanthus, Convallaria, and Drimia.
Chemical Constituents
Cardenolides and bufadienolides.
Active Principles
Digoxin, digitoxin, ouabain, convallatoxin, and related compounds.
Therapeutic Importance
Primarily cardiovascular effects, especially positive inotropy and AV nodal effects.
Quality Control
Because of their potency and toxicity, proper identification, standardization, and quantitative analysis are essential.
Cardiac Glycosides: Quick Revision
Cardiac glycosides → Steroidal glycosides with cardiac activity
Main structural components:
- Steroid nucleus
- Sugar moiety
- Unsaturated lactone ring
Major classes:
- Cardenolides
- Bufadienolides
Important cardenolide:
- Digoxin
Major source of digoxin:
- Digitalis lanata
Important source of digitoxin:
- Digitalis purpurea
Mechanism:
- Inhibition of Na⁺/K⁺-ATPase
Major cardiac effect:
- Increased myocardial contractility
Important toxicity concern:
- Cardiac arrhythmias
Frequently Asked Questions About Cardiac Glycosides
What are cardiac glycosides?
Cardiac glycosides are steroidal glycosides that exert powerful effects on cardiac muscle. They can increase the force of cardiac contraction and affect heart rate and AV nodal conduction.
What are the two major types of cardiac glycosides?
The two major types are cardenolides and bufadienolides.
What is the most important cardiac glycoside?
Digoxin is one of the most clinically important cardiac glycosides.
Which plant is the source of digoxin?
Digoxin is primarily associated with Digitalis lanata.
Which plant contains digitoxin?
Digitoxin is associated particularly with Digitalis purpurea.
How do cardiac glycosides work?
They inhibit Na⁺/K⁺-ATPase, increasing intracellular calcium in cardiac muscle and thereby increasing the force of contraction.
Why are cardiac glycosides toxic?
They have a narrow therapeutic index, so concentrations that are only modestly above the therapeutic range can produce serious adverse effects, including potentially dangerous arrhythmias.
Conclusion
Cardiac glycosides are an important class of naturally derived steroidal compounds with significant pharmacological activity. The two major groups are cardenolides and bufadienolides, distinguished mainly by the structure of their lactone ring.
Plants such as Digitalis purpurea, Digitalis lanata, Strophanthus species, Convallaria majalis, and Drimia maritima are important natural sources of these compounds. Digoxin remains the best-known example.
Their ability to inhibit Na⁺/K⁺-ATPase produces characteristic cardiovascular effects, particularly increased myocardial contractility and, for digoxin, effects on AV nodal conduction. However, their narrow therapeutic index means that cardiac glycosides require careful dosing and clinical monitoring.
For students of pharmacognosy, pharmacology, pharmacy, and pharmaceutical sciences, cardiac glycosides are an important example of how medicinal plants can provide potent biologically active compounds that become clinically useful medicines.
Related Topics
- [O-Glycosides]
- [C-Glycosides]
- [N-Glycosides]
- [S-Glycosides (Thioglycosides)]
- [Classification of Glycosides]
- [Digitalis]
- [Digoxin]
- [Cardenolides]
- [Bufadienolides]
- [Pharmacognosy of Cardiac Glycosides]
Suggested URL Slug: /glycosides/cardiac-glycosides/
Suggested SEO Tags: Cardiac Glycosides, Cardiac Glycosides Classification, Cardiac Glycosides Examples, Digoxin, Digitoxin, Digitalis, Cardenolides, Bufadienolides, Pharmacognosy, Glycosides, Cardiac Glycosides Mechanism of Action